Invention Application
- Patent Title: TRANSFECTION METHOD
-
Application No.: US17622585Application Date: 2019-06-26
-
Publication No.: US20220249665A1Publication Date: 2022-08-11
- Inventor: Naoyuki MURATA , Shigeo YANAI
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Chuo-ku, Osaka-shi, Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Chuo-ku, Osaka-shi, Osaka
- International Application: PCT/JP2019/025506 WO 20190626
- Main IPC: A61K41/00
- IPC: A61K41/00 ; C12N15/88 ; A61K48/00 ; C12N15/113

Abstract:
A novel means for safely and efficiently introducing a target substance such as nucleic acid, protein, or the like into cells (excluding immune cells) is provided by the present invention. Specifically, a system for delivering a target substance into a cell (excluding immune cells), including ultrafine bubble water or ultrafine bubble aqueous solution containing ultrafine bubbles with an average diameter of not more than 200 nm and not containing phospholipid, and an ultrasound generator in combination; a method for increasing the delivery of a nucleic acid, a protein or a low-molecular-weight compound into a cell (excluding immune cells) by using the ultrafine bubble water, etc.; and the like are provided.
Information query